Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET and MRI Imaging of Persistent Lyme Encephalopathy
NCT00037479Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Dec 1999
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Lyme neuroborreliosis (LNB) comparing Ceftriaxone with Placebo (2 arms). Primary endpoint: Neuropsychological testing of memory and attention at 24 weeks. Started Dec 1999; status: completed.
02
Drugs
ceftriaxone
03
Conditions
Lyme neuroborreliosis (LNB)
Beyond the preview
Go deeper on NCT00037479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037479.